Posts Tagged ‘Funding’
Moonlight AI AG Raises $3.3M Seed Round
Moonlight AI AG, a Swiss startup building image analysis software for clinical-grade diagnostics, has closed a $3.3 million USD Seed round. The investment was co-led by Lotus One Investment (Singapore), VP Venture Partners (Switzerland), and MEDIN Fund (Tunisia), with participation from N&V Capital (Liechtenstein) and existing investor QAI Ventures (Switzerland). Turning routine slide images into…
Read MoreSwiss Biotech on the Rise: Strong Momentum in 2025
Switzerland’s biotech sector continues to demonstrate remarkable resilience and growth, even in a complex global environment. According to the latest Swiss Biotech Report 2026, the industry reached new heights in 2025—both in terms of revenue and investment—further strengthening the country’s position as a global life sciences powerhouse. Record performance in a challenging context The numbers…
Read MoreTwo Research Teams from HUG and UNIGE Awarded the 2026 Leenaards Scientific Prize
Two research groups from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE) have been awarded the 2026 Leenaards Foundation Scientific Prize, with total funding of nearly CHF 1.4 million. The award supports two biomedical research projects conducted in the Lake Geneva region, focusing respectively on hepatitis E and an innovative, non-invasive approach to…
Read MoreMindMaze Therapeutics Narrows Losses and Prepares for Commercial Takeoff in 2026
MindMaze Therapeutics’ 2025 Annual Report tells a story of transition—one where financial discipline begins to align with long-term commercial ambition. The Swiss-based neurotechnology company gears up for a broader market launch in 2026. Mindmaze reported CHF 0.6 million in revenue for 2025, alongside operating expenses of CHF 11.2 million and a net loss of CHF…
Read MoreThree Life Sciences Companies Finalist of the Strategis Award
The jury of the Prix Strategis selected five companies, to advance to the final round of the competition. Three of them are Swiss Health Valley projects. Irmos Technologies AG, which develops solutions to extend the lifespan of infrastructure. Neology SA, which offers a clean alternative to diesel. Virtuosis AI, specialized in intelligent vocal biomarkers. Isospec…
Read MoreEPFL Innogrants
Five EPFL-based life sciences startups, Alpion CryoSolutions, Eleum, Feedback Intuitive, MOLECL, and NourishAI are the latest recipients of the EPFL Startup Launchpad Innogrant and Innogrant for biotherapeuthics. Each team has secured CHF 100,000 to accelerate the development of their technology. Alpion CryoSolutions Cryo-electron microscopy has transformed biology by allowing researchers to see proteins in extraordinary detail. However, existing…
Read MoreAC Immune and Eli Lilly Sign New Agreement Worth CHF 10 Million
Eli Lilly has handed Vaud-based AC Immune (Switzerland) 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC Immune in a 2018 deal that included an $81 million upfront fee. That pact, which came with up to 1.7 billion francs ($2.1 billion)…
Read More“Towards Shared Health”: A New Initiative to Transform the Swiss Healthcare System
The Leenaards Foundation has launched its new initiative, “Vers une santé partagée” (Towards Shared Health), a five-year program (2026–2030) designed to support the transformation of Switzerland’s healthcare system. With an annual budget of up to CHF 1.75 million, the initiative aims to encourage innovative approaches that promote a more accessible, sustainable, and equitable health system.…
Read MoreVenture Leaders Biotech 2026: 10 innovative biotech startups selected for the Boston roadshow
Ten startups, 4 of them from the Swiss Health Valley, have been selected for the 2026 Venture Leaders Biotech programme, which will take them to Boston from May 31st to June 5th as part of the Swiss National Startup Team. During their roadshow, the entrepreneurs will connect with international investors and industry leaders, acquiring expertise…
Read MorePolares Medical Raises $50 million in Series C Funding
The funding was supported by DC Global Ventures, Lumination Capital, existing investors and a new strategic investor, to help advance MRace‘s US expansion following strong clinical results. Polares Medical SA (‘Polares’), a Swiss Health Valley clinical-stage structural heart company developing the MRace mitral valve replacement system for mitral valve regurgitation (MR), announced the closing of…
Read More